Enhabit, Inc. (NYSE:EHAB) Receives $12.08 Average PT from Analysts

Shares of Enhabit, Inc. (NYSE:EHAB) have earned a consensus recommendation of “Reduce” from the seven analysts that are currently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $12.08.

Several equities research analysts recently issued reports on EHAB shares. Oppenheimer restated a “market perform” rating on shares of Enhabit in a research report on Thursday, March 7th. UBS Group upgraded shares of Enhabit from a “sell” rating to a “neutral” rating and set a $9.50 price objective for the company in a research report on Thursday, March 7th. Finally, Jefferies Financial Group cut their price objective on shares of Enhabit from $15.00 to $14.00 and set a “buy” rating for the company in a research report on Wednesday, March 6th.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of EHAB. JANA Partners Management LP purchased a new position in Enhabit during the third quarter worth about $20,532,000. UBS Group AG boosted its stake in shares of Enhabit by 7,973.5% in the third quarter. UBS Group AG now owns 1,633,751 shares of the company’s stock valued at $18,380,000 after purchasing an additional 1,613,515 shares during the period. Ancora Advisors LLC boosted its stake in shares of Enhabit by 414.5% in the third quarter. Ancora Advisors LLC now owns 1,705,788 shares of the company’s stock valued at $19,190,000 after purchasing an additional 1,374,231 shares during the period. DekaBank Deutsche Girozentrale boosted its stake in shares of Enhabit by 12,146.2% in the fourth quarter. DekaBank Deutsche Girozentrale now owns 244,924 shares of the company’s stock valued at $2,543,000 after purchasing an additional 242,924 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Enhabit by 25.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 966,515 shares of the company’s stock valued at $10,003,000 after purchasing an additional 193,675 shares during the period.

Enhabit Price Performance

Shares of NYSE EHAB opened at $10.18 on Thursday. The firm has a 50-day simple moving average of $10.25 and a 200-day simple moving average of $9.89. The stock has a market capitalization of $510.63 million, a price-to-earnings ratio of -6.28, a price-to-earnings-growth ratio of 1.57 and a beta of 1.96. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.76. Enhabit has a 52 week low of $7.12 and a 52 week high of $14.59.

Enhabit (NYSE:EHAB) last released its quarterly earnings data on Wednesday, March 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.01. Enhabit had a negative net margin of 7.69% and a positive return on equity of 1.55%. The firm had revenue of $260.60 million during the quarter, compared to analysts’ expectations of $260.30 million. During the same period last year, the business earned $0.32 earnings per share. On average, equities analysts predict that Enhabit will post 0.24 earnings per share for the current fiscal year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.